1-6 of 6
Alessandra Serrao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world effectiveness of gilteritinib beyond second-line therapy in relapsed/refractory FLT3-mutated acute myeloid leukemia: A european multicenter study of 171 patients

Free
Matteo Molica, Gema Miralles, Richard Dillon, Mario Annunziata, Faisal Basheer, Juan Miguel Bergua Burgues, Ferran Vall-Llovera Calmet, Victoria Campbell, Denis Cetin, Gaetano Cimino, Giulia Ciotti, andrea corbingi, LAURA DE FAZIO, Hasim Atakan Erol, Vincenzo Federico, Cristina Gil, Yasa Mutlu Gulu, Amaia Balerdi Malcorra, Sabrina Mariani, Maria Paola Martelli, Carla Mazzone, Antonino Mulè, Gerardo Musuraca, Anjum Khan, Mariana Norata, Jenny O'Nions, Fanny Palumbo, Cristina Papayannidis, Annalina Piccioni, Maria Teresa Olave Rubio, Jackeline Sanchez-Tovar, Istemi Serin, Alessandra Serrao, Omur Sevindik, Giuseppe Sucato, Marina Aurora Urbano, Calogero Vetro, Susana Vives, Marco Rossi, Pau Montesinos, Jad Othman, Salvatore Perrone
Journal: Blood
Blood (2025) 146 (Supplement 1): 1662.
https://doi.org/10.1182/blood-2025-1662
Published: 2025
Journal Articles

Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study

Free
Antonio Russo, MD, Alessandro Pulsoni, MD, Simonetta Viviani, MD, Francesca Ricci, MD, Rita Mazza, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesco Landi, MD, Anna Guidetti, MD, Michele Merli, MD, Marcello Rodari, MD, Alessandra Serrao, MD, Giorgia Annechini, MD, Andrea Nervini, MD, Laura Giordano, Luca Castagna, MD, Francesco Passamonti, MD, Arturo Chiti, MD, Paolo Corradini, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1655.
https://doi.org/10.1182/blood-2018-99-115313
Published: 2018
Journal Articles

Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?

Free
Roberto Latagliata, MD, Ida Carmosino, Federico Vozella, Paola Volpicelli, MD, Giuseppina Loglisci, Michelina Santopietro, Adriano Salaroli, MD, Angela Romano, Chiara Montagna, Amanda Roberto, Alessandra Serrao, Daniela Diverio, PhD, Mauro Nanni, PhD, Marco Mancini, Agostino Tafuri, Massimo Breccia, Giuliana Alimena, MD
Journal: Blood
Blood (2013) 122 (21): 4002.
https://doi.org/10.1182/blood.V122.21.4002.4002
Published: 2013
Journal Articles

Delayed Cytogenetic Response and Reduced Rate of Major Molecular Response Associated to Increased Body Mass Index At Baseline in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib.

Free
Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Paola Volpicelli, MD, Daniela Diverio, PhD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 2784.
https://doi.org/10.1182/blood.V120.21.2784.2784
Published: 2012
Journal Articles

Long-Term Follow-up of Chronic Phase Chronic Myeloid Leukemia Patients Who Failed Interferon Alpha and Switched to Imatinib

Free
Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Irene Zacheo, MD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 3742.
https://doi.org/10.1182/blood.V120.21.3742.3742
Published: 2012
Journal Articles

MDS-Specific Comorbidity Index (MDS-CI) Identifies Overall Survival Differences in Myelodysplastic Syndrome Patients,

Free
Massimo Breccia, Vincenzo Federico, Giuseppina Loglisci, Roberto Latagliata, Michelina Santopietro, Adriano Salaroli, Alessandra Serrao, Gioia Colafigli, Agostino Tafuri, Giuliana Alimena
Journal: Blood
Blood (2011) 118 (21): 3793.
https://doi.org/10.1182/blood.V118.21.3793.3793
Published: 2011